CVE-2016-8355 Privilege escalation in Smiths-Medical CADD-Solis Medication Safety Software through 3.1
Authenticated users can gain elevated SQL database privileges to modify drug libraries and user permissions in Smiths-Medical CADD-Solis software.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2016-8355?
CVE-2016-8355 is a critical vulnerability in Smiths-Medical CADD-Solis Medication Safety Software through 3.1, published on 13 Feb 2017. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
Weakness: CWE-306
Which versions are affected by CVE-2016-8355?
It affects 1 product.
Products include Smiths-Medical Cadd-Solis Medication Safety Software.
How do I fix CVE-2016-8355?
No fix has been published for CVE-2016-8355 yet. Limit exposure of the affected software until one is available.
Is CVE-2016-8355 being exploited?
There is no known exploitation of CVE-2016-8355 in the wild and no public exploit code.
Other vulnerabilities in Smiths-Medical CADD-Solis Medication Safety Software through 3.1
Sources
Also known as GHSA-2h29-mg3v-85xj.